US5322775A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Peptide production
Assignee: Pharmaceutical Proteins Ltd
•
Filing: 1991-11-22
•
Granted: 1994-06-21
•
Expires: 2011-11-22
Abstract
Abstract A method of producing a proteinaceous compound, involves incorporating a DNA sequence coding for a polypeptide chain of said compound into a gene of a mammal (such as a sheep) coding for a milk whey protein in such a way that the DNA sequence is expressed in the mammary gland of the adult female mammal. The proteinaceous compound may be a (optionally modified) protein such as a blood coagulation factor. The DNA sequence is preferably inserted into the first exon of a gene coding for a whey protein such as beta-lactoglobulin. The proteinaceous compound will generally be recovered from milk of the female mammal, but may (for example if it is an enzyme) be used in situ.
Inventors
- 👤 Anthony J. Clark
- 👤 Richard Lathe
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-25 10:09
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/63; C12N15/79; C12N15/85; C12N15/8509; A; A01; A01K; A01K67/00; A01K67/027; A01K67/0275; A01K67/0278; C12N15/87; C12N15/89; A01K2207/00; A01K2207/15; A01K2217/00; A01K2217/05; A01K2227/00; A01K2227/10; A01K2227/103; A01K2227/105; A01K2267/00; A01K2267/01
Claims Analysis
Total Claims: 18
Claim 1
Independent Claim
109 words
A method of producing a proteinaceous compound, the method comprising the steps of (a) producing milk in a female transgenic, non-human placental mammal, said mammal containing a transgene construct in its somatic and germ cells, said construct comprising (i) a DNA sequence encoding a polypeptide chain of said proteinaceous compound; and (ii) a β-lactoglobulin promoter operatively linked to said DNA sequence encoding said polypeptide chain; said transgene construct being integrated in such a way that said DNA sequence encoding said polypeptide chain is expressed in the mammary gland of said female mammal and said polypeptide is present in said milk; and (b) collecting the milk produced in step (a).
Claim 2
Independent Claim
109 words
A method of producing a proteinaceous compound, the method comprising the steps of (a) producing milk in a female transgenic, non-human placental mammal, said mammal containing a transgene construct in its somatic and germ cells, said construct comprising (i) a DNA sequence encoding a polypeptide chain of said proteinaceous compound; and (ii) a β-lactoglobulin promoter operatively linked to said DNA sequence encoding said polypeptide chain; said transgene construct being integrated in such a way that said DNA sequence encoding said polypeptide chain is expressed in the mammary gland of said female mammal and said polypeptide is present in said milk; and (b) collecting the milk produced in step (a).
Claim 3
Independent Claim
129 words
A method of producing a substance which is the reaction product of an enzyme which catalyzes the formation of said reaction product from one or more substrates of said enzyme present in milk, the method comprising the steps of (a) producing milk in a female, transgenic, non-human, placental mammal, said mammal containing a transgene construct in its somatic and germ cells, said construct comprising (i) a DNA sequence encoding said enzyme; and (ii) a β-lactoglobulin promoter operatively linked to said DNA sequence encoding said enzyme; said transgene construct being integrated in such a way that said DNA sequence encoding said enzyme is expressed in the mammary gland of said female mammal, whereby said reaction product is produced in said milk; and (b) collecting the milk produced in step (a).
Claim 4
Independent Claim
129 words
A method of producing a substance which is the reaction product of an enzyme which catalyzes the formation of said reaction product from one or more substrates of said enzyme present in milk, the method comprising the steps of (a) producing milk in a female, transgenic, non-human, placental mammal, said mammal containing a transgene construct in its somatic and germ cells, said construct comprising (i) a DNA sequence encoding said enzyme; and (ii) a β-lactoglobulin promoter operatively linked to said DNA sequence encoding said enzyme; said transgene construct being integrated in such a way that said DNA sequence encoding said enzyme is expressed in the mammary gland of said female mammal, whereby said reaction product is produced in said milk; and (b) collecting the milk produced in step (a).
Claim 5
Dependent Claim
18 words
A method as claimed in claim 1 further comprising: (c) recovering said proteinaceous compound from the collected milk.
Claim 6
Dependent Claim
24 words
A method as claimed in claim 1, wherein the proteinaceous compound is a blood coagulation factor or a subunit of a blood coagulation factor.
Claim 7
Dependent Claim
17 words
A method as claimed in claim 2, wherein the reaction product is recovered from the collected milk.
Claim 8
Dependent Claim
14 words
A method as claimed in claim 2, wherein the mammal is a dairy sheep.
Claim 9
Dependent Claim
20 words
A method as claimed in claim 1 or 2, wherein said transgene construct also comprises a start site for transcription.
Claim 10
Dependent Claim
23 words
A method as claimed in claim 1 or 2, wherein said transgene construct also comprises a 3' sequence flanking a milk protein gene.
Claim 11
Dependent Claim
19 words
A method as claimed in claim 1, wherein said transgene construct comprises a signal peptide for the polypeptide chain.
Claim 12
Independent Claim
32 words
A method as claimed in any one of claims 1 or 2, wherein the 3' end of the DNA sequence terminates after its stop codon, but before its own polyA addition site.
Claim 13
Dependent Claim
45 words
A method as claimed in claim 1, wherein said transgene construct additionally comprises one or more of: (a) a 5' regulatory sequence (in addition to the promoter) of a β-lactoglobulin gene; (b) structural β-lactoglobulin sequences; or (c) the 3' sequences normally flanking a β-lactoglobulin gene.
Claim 14
Dependent Claim
45 words
A method as claimed in claim 2, wherein said transgene construct additionally comprises one or more of: (a) a 5' regulatory sequence (in addition to the promoter) of a β-lactoglobulin gene; (b) structural β-lactoglobulin sequences; or (c) the 3' sequences normally flanking a β-lactoglobulin gene.
Claim 15
Dependent Claim
14 words
A method as claimed in claim 1, wherein the proteinaceous compound is Factor IX.
Claim 16
Dependent Claim
15 words
A method as claimed in claim 1, wherein the proteinaceous compound is alpha 1 -antitrypsin.
Claim 17
Dependent Claim
21 words
A method as claimed in claim 1, wherein said DNA sequence encoding said polypeptide chain of said proteinaceous compound is cDNA.
Claim 18
Dependent Claim
35 words
A method as claimed in claim 9, wherein said signal peptide is a β-lactoglobulin signal peptide and wherein said signal peptide is fused to said DNA sequence encoding said polypeptide chain of said proteinaceous compound.
References Cited (Backward Citations)
WO1982004443A1
Cited
US4870009A
Cited
US4736866A
Cited
US4736866B1
Cited
EP0264166B1
Cited
US4873316A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1997-06-20 | 1997-12-20 | 1998-06-21 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2001-06-20 | 2001-12-20 | 2002-06-21 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2005-06-20 | 2005-12-20 | 2006-06-21 | $7700.00 | Window Closed / Lapsed |